Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Pleased to share our new publication in Research and Practice in Thrombosis and Haemostasis:
‘Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry.’
In this RIETE Registry analysis of 1,186 patients with VTE receiving retrievable IVC filters, filter retention was associated with worse outcomes compared with filter removal.
Key findings:
- Higher VTE recurrence with retained filters: 7.5 percent versus 1.8 percent
- Recurrences were mainly driven by DVT.
- Filter removal was associated with lower adjusted risk of VTE recurrence
- All-cause mortality was higher in patients with retained filters: 17.0 percent versus 6.3 percent
- Major bleeding remained infrequent and was not significantly different between groups.
Clinical message: retrievable IVC filters require structured follow-up and timely removal whenever clinically feasible.
Grateful to Omri Cohen, Manuel Monreal, the RIETE investigators, and all co-authors for the collaboration.
The accompanying image was AI-generated – with supervision – to present the study on LinkedIn.”
Title: Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry
Authors: Omri Cohen, Davide Santagata, Gili Kenet, Juan José López-Núñez, My Hanh Bui, Andris Skride, Patricia López-Miguel, Raimundo Tirado, Fernando Arméstar, Manuel Monreal
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH